C-MER Eye Care Holdings Limited

HKEX:3309.HK

2.11 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q4
Revenue 973.701950.263850.339881.564591.133521.444437.779261.766311.615264.594237.06192.314170.779140.449133.349115.3162.16549.71349.71349.71349.71339.11839.11839.11839.118
Cost of Revenue 654.891650.111648.686667.788440.427362.71321.98213.32219.593165.295150.792129.24598.04277.75581.66572.01838.42129.78829.78829.78829.78824.35724.35724.35724.357
Gross Profit 318.81300.152201.653213.776150.706158.734115.79948.44692.02299.29986.26863.06972.73762.69451.68443.29223.74419.92519.92519.92519.92514.76114.76114.76114.761
Gross Profit Ratio 0.3270.3160.2370.2420.2550.3040.2650.1850.2950.3750.3640.3280.4260.4460.3880.3750.3820.4010.4010.4010.4010.3770.3770.3770.377
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 176.207178.721186.12159.227129.545104.5786.43252.84456.85641.56736.34828.51926.75216.83216.45814.0767.4626.5246.5246.5246.5246.8826.8826.8826.882
Selling & Marketing Expenses 78.71469.08872.32454.4574.76551.67746.39623.48927.76718.53317.479.0317.0284.2354.2533.6211.9691.1741.1741.1741.1740.730.730.730.73
SG&A 255.058247.809258.451181.287175.646136.123111.25366.71383.97659.48153.81837.5533.7821.06720.71117.6979.437.6977.6977.6977.6977.6117.6117.6117.611
Other Expenses 000000000000000-9.446-9.446-7.691-7.691-7.691-7.691-7.616-7.616-7.616-7.616
Operating Expenses 253.885242.576233.786181.287175.646136.123111.25366.71383.97659.48153.91347.49548.89128.37619.15217.043-0.0160.0060.0060.0060.006-0.005-0.005-0.005-0.005
Operating Income 67.55356.955-40.85432.489-24.9422.6114.546-18.2678.04639.81832.74126.09940.10842.00631.41125.90714.88212.40512.40512.40512.4057.2327.2327.2327.232
Operating Income Ratio 0.0690.06-0.0480.037-0.0420.0430.01-0.070.0260.150.1380.1360.2350.2990.2360.2250.2390.250.250.250.250.1850.1850.1850.185
Total Other Income Expenses Net -0.4570.2184.512-23.61718.703-0.15116.939-0.4381.853.696.313-3.987-15.905-7.7230.9420.336-0.233-0.297-0.297-0.297-0.297-0.242-0.242-0.242-0.242
Income Before Tax 67.09657.173-36.3428.872-6.23722.4621.485-18.7059.89643.50839.05422.11224.20334.28332.35326.24314.64912.10812.10812.10812.1086.9916.9916.9916.991
Income Before Tax Ratio 0.0690.06-0.0430.01-0.0110.0430.049-0.0710.0320.1640.1650.1150.1420.2440.2430.2280.2360.2440.2440.2440.2440.1790.1790.1790.179
Income Tax Expense 18.75819.17613.42821.570.9959.657.5283.3883.70410.3828.50410.0919.4328.9276.0425.6672.9272.5192.5192.5192.5191.4011.4011.4011.401
Net Income 32.2429.758-36.6914.8158.14913.71214.735-20.9817.67833.75730.5512.02114.77125.35626.31120.57611.7229.5899.5899.5899.5895.595.595.595.59
Net Income Ratio 0.0330.031-0.0430.0170.0140.0260.034-0.080.0250.1280.1290.0630.0860.1810.1970.1780.1890.1930.1930.1930.1930.1430.1430.1430.143
EPS 0.0260.024-0.030.0120.0070.0120.013-0.020.0070.0320.0290.0120.0180.0340.0360.0290.0120.010.010.010.010.0060.0060.0060.006
EPS Diluted 0.0260.024-0.030.0120.0070.0120.013-0.020.0070.0320.0290.0120.0180.0340.0360.0290.0120.010.010.010.010.0060.0060.0060.006
EBITDA 106.53597.4822.728142.83253.82192.43163.9135.93151.52274.8845.28939.09744.79845.89437.48432.25217.98715.315.315.315.39.9759.9759.9759.975
EBITDA Ratio 0.1090.1030.0030.1620.0910.1770.1460.1370.1650.2830.1910.2030.2620.3270.2810.280.2890.3080.3080.3080.3080.2550.2550.2550.255